About
Overview
Leadership
Science
Overview
Publications
Platform
Pipeline
News
Contact
Search
Menu
Menu
News & Events
Stay up to date on new developments
April 1, 2021
Revere Pharma Announces Publication of Research that Elaborates Role of Rac1 in Prostate Cancer
Read More
February 22, 2021
Revere Pharmaceuticals Announces Asset Purchase Agreement to Acquire All Assets of Geneyus LLC
Read More
February 22, 2021
Revere Pharmaceuticals Expands Board of Directors to Include Marc Lippman, MD
Read More
February 1, 2021
Revere Pharmaceuticals Enters Exclusive Option and License Agreement with Fosun USA to Develop and Commercialize Products Targeting Rac1 and Cdc42 in China
Read More
